Polaris Capital Picks Up $6.28M Eastman Chemical Stake, 1.28% Portfolio Impact
Bernard Horn’s Polaris Capital purchased 82,300 Eastman Chemical shares valued at $6.28 million, increasing its portfolio weight by 1.28% in Q1 2026. The move reflects the fund’s emphasis on undervalued global chemical firms with sustainable free cash flow.
1. Portfolio Addition Details
Bernard Horn’s Polaris Capital acquired 82,300 Eastman Chemical shares in the first quarter of 2026, investing $6.28 million and boosting its portfolio allocation by 1.28%. This was the most significant new position in the period, highlighting Eastman’s appeal within the fund’s global holdings.
2. Alignment with Global Value Philosophy
The acquisition aligns with Polaris Capital’s strategy targeting undervalued companies with strong sustainable free cash flow. Eastman’s diversified chemicals business and asset valuation fit the fund’s criteria for securities mispriced due to macroeconomic and industry fluctuations.